TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Janssons Immunbiologiska AB JIBA
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 4,185 | 4,130 | 4,763 |
Financial expenses | 2 | 5 | 5 |
Earnings before taxes | 803 | 801 | 1,494 |
EBITDA | 803 | 805 | 1,503 |
Total assets | 2,205 | 2,200 | 1,876 |
Current assets | 2,205 | 2,200 | 1,876 |
Current liabilities | 375 | 402 | 599 |
Equity capital | 1,830 | 1,798 | 1,272 |
- share capital | 67 | 67 | 73 |
Employees (average) | 2 | 2 | 5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 83.0% | 81.7% | 67.8% |
Turnover per employee | 2,092 | 2,065 | 953 |
Profit as a percentage of turnover | 19.2% | 19.4% | 31.4% |
Return on assets (ROA) | 36.5% | 36.6% | 79.9% |
Current ratio | 588.0% | 547.3% | 313.2% |
Return on equity (ROE) | 43.9% | 44.5% | 117.5% |
Change turnover | 34 | -247 | -408 |
Change turnover % | 1% | -6% | -8% |
Chg. No. of employees | 0 | -3 | 0 |
Chg. No. of employees % | 0% | -60% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.